<SEC-DOCUMENT>0000950103-25-005798.txt : 20250507
<SEC-HEADER>0000950103-25-005798.hdr.sgml : 20250507
<ACCEPTANCE-DATETIME>20250507071548
ACCESSION NUMBER:		0000950103-25-005798
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250507
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250507
DATE AS OF CHANGE:		20250507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
		CENTRAL INDEX KEY:			0001100682
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				061397316
		FISCAL YEAR END:			1227

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15943
		FILM NUMBER:		25919265

	BUSINESS ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		781-222-6000

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES INTERNATIONAL INC
		DATE OF NAME CHANGE:	20000605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19991208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dp228602_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CRL="http://crl.com/20250507">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_CRL_crl.com_20250507 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250507_20250507 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001100682 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000004" name="dei:EntityCentralIndexKey">0001100682</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="crl-20250507.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001100682</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-07</xbrli:startDate>
        <xbrli:endDate>2025-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20250507__20250507_zgchFUkFhb93"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>CURRENT
REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20250507__20250507_zalIqAUlFTLg"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 7, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20250507__20250507_zv4zi2xgOsM4"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000011" name="dei:EntityRegistrantName">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; font-size: 12pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250507__20250507_zkkvWvThDZId"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 20%; font-size: 12pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20250507__20250507_za0YI0J1gAsb"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000013" name="dei:EntityFileNumber">001-15943</ix:nonNumeric></span></b></span></td>
    <td style="width: 40%; font-size: 12pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250507__20250507_zmb0XPMBfRu5"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000014" name="dei:EntityTaxIdentificationNumber">06-1397316</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction of Incorporation)</p></td>
    <td style="vertical-align: top; font-size: 12pt; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20250507__20250507_z9qaoOvdS2k8"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000015" name="dei:EntityAddressAddressLine1">251 Ballardvale Street</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20250507__20250507_zAshWYgRPD1e"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000016" name="dei:EntityAddressCityOrTown">Wilmington</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20250507__20250507_zi5UeP9U4fql"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20250507__20250507_zSQHvEPfNAff"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000018" name="dei:EntityAddressPostalZipCode">01887</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--CityAreaCode_c20250507__20250507_zENuRyXUqDz6"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000019" name="dei:CityAreaCode">781</ix:nonNumeric></span>-<span id="xdx_90E_edei--LocalPhoneNumber_c20250507__20250507_z06NIyN3eHZa"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000020" name="dei:LocalPhoneNumber">222-6000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone Number, including
Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(b)
of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 40%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="width: 20%; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="width: 40%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-top: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20250507__20250507_zpfqNGQBkxRa"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000021" name="dei:Security12bTitle">Common stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="border-top: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250507__20250507_zDKQoTgFTeRl"><ix:nonNumeric contextRef="AsOf2025-05-07" id="Fact000022" name="dei:TradingSymbol">CRL</ix:nonNumeric></span></span></td>
    <td style="border-top: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--SecurityExchangeName_c20250507__20250507_zpxFEkTymEU7"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt-sec:exchnameen" id="Fact000023" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--WrittenCommunications_c20250507__20250507_zsGlAYVGGu7c"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000024" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td><span style="font-size: 10pt">Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20250507__20250507_zrhGwfnhvJOg"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleantrue" id="Fact000025" name="dei:SolicitingMaterial">&#9746;</ix:nonNumeric></span></span></td><td><span style="font-size: 10pt">Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementTenderOffer_c20250507__20250507_zjCwDtpH1Pna"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250507__20250507_zJwfeZGTanI4"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000027" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the Registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20250507__20250507_zDsvCmhf8in8"><ix:nonNumeric contextRef="AsOf2025-05-07" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the Registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 1.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 6, 2025 (the &#8220;Effective Date&#8221;),
Charles River Laboratories International, Inc. (the &#8220;Company&#8221;) entered into a Cooperation Agreement (the &#8220;Cooperation
Agreement&#8221;) by and among Elliott Investment Management L.P., a Delaware limited partnership, Elliott Associates, L.P., a Delaware
limited partnership and Elliott International, L.P., a Cayman Islands limited partnership (each, an &#8220;Elliott Party,&#8221; and collectively,
the &#8220;Elliott Parties&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Cooperation Agreement, the
Company has agreed to, among other things, (i) appoint (a) Steven Barg (the &#8220;Investor Director&#8221;) and Mark Enyedy (and
together with the Investor Director, the &#8220;Investor Designated Directors&#8221;) and (b) appoint Abraham Ceesay and Paul Graves
(the &#8220;New Company Directors&#8221;, and together with the Investor Designated Directors, the &#8220;Cooperation Agreement
Directors&#8221;) to the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), effective following the Company&#8217;s 2025
Annual Meeting of Stockholders (the &#8220;2025 Annual Meeting&#8221;, and such date of appointment, the &#8220;Appointment
Date&#8221;), each with a term expiring at the 2026 Annual Meeting of Stockholders (the &#8220;2026 Annual Meeting&#8221;); and (ii)
announce that four incumbent Directors as of the Effective Date will not stand for re-election to the Board at the 2025 Annual
Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Cooperation Agreement further provides that
in the event that (i) any Investor Designated Director is unable or unwilling to serve as a Director, resigns as a Director, is removed
as a Director or ceases to be a Director of the Company for any other reason prior to the expiration of the Cooperation Period (as defined
below), the Company shall appoint a substitute director selected by the Elliott Parties and reasonably acceptable to the Company; and
(ii) any New Company Director is unable or unwilling to serve as a Director, resigns as a Director, is removed as a Director or ceases
to be a Director of the Company for any other reason prior to the expiration of the Cooperation Period, the Company shall appoint a substitute
director selected by the Company and reasonably acceptable to the Elliott Parties; provided, that, in each case, at such time the Elliott
Parties beneficially own a &#8220;net-long position&#8221; of, or have aggregate net-long economic exposure to, at least 3% of the Company&#8217;s
then-outstanding common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has also agreed that, as soon as reasonably
practicable following the Appointment Date, the Board shall appoint at least one Investor Designated Director to each of the Strategic
Partnership and Capital Allocation Committee of the Board of Directors (the &#8220;Strategic Committee&#8221;), the Compensation Committee
of the Board of Directors, and the Corporate Governance and Nominating Committee of the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Cooperation Agreement also provides that, following
the Effective Date, the Board (through the Strategic Committee) will conduct a comprehensive review and evaluation of the Company&#8217;s
business and prospects, including an examination of various alternatives to enhance long-term stockholder value. The Company further agreed,
as part of this review, to appoint both Investor Designated Directors to the Strategic Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Cooperation Agreement includes certain voting
commitments, customary standstill restrictions and mutual non-disparagement provisions that remain in place until the later of (x) the
date that is 30 calendar days prior to the advance notice deadline under the Company&#8217;s Sixth Amended and Restated Bylaws for the
nomination of non-proxy access Director candidates for election to the Board at the Company&#8217;s 2026 Annual Meeting of Stockholders
and (y) the first day on which the Investor Director (or any replacement for the Investor Director who is an employee of an Elliott Party)
ceases to serve as a member of the Board (such period, the &#8220;Cooperation Period&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information set forth under Item 5.02 of this
Current Report on Form 8-K is incorporated into this Item 1.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Cooperation Agreement is attached hereto as
Exhibit 10.1 and is incorporated herein by reference. The description of the Cooperation Agreement herein does not purport to be complete
and is qualified in its entirety by reference to Exhibit 10.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 5.02</b></span></td>
    <td><span style="font-size: 10pt"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Item 5.02(b)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 6, 2025, Robert Bertolini, Deborah T. Kochevar,
George E. Massaro and Richard F. Wallman each notified the Company of his or her decision to not stand for re-election to the Board at
the 2025 Annual Meeting following the expiration of their respective terms prior to the 2025 Annual Meeting (resulting in four vacancies
on the Board). None of the departures from the Board described herein are due to any disagreement with the Company on any matter relating
to the Company&#8217;s operations, policies or practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Item 5.02(d)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Cooperation Agreement, the Board
has agreed to, as promptly as practical following the Annual Meeting of Stockholders scheduled for May 20, 2025, to elect the Cooperation
Agreement Directors as members of the Board (to fill the vacancies described in the preceding paragraph), effective immediately following
such election, each with a term expiring at the 2026 Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Non-employee members of the Company&#8217;s Board,
including the Cooperation Agreement Directors, will be entitled to participate in the non-employee director compensation program arrangements
generally applicable to all of the Registrant&#8217;s non-employee directors. Under the terms of those arrangements, as currently in effect,
new directors initially appointed after the 2025 Annual Meeting will receive an initial equity award and cash retainer for board and board
committee services on a pro-rata basis calculated at the time of service. The initial equity award (before pro-rata adjustment) has a
value of $255,500 and will be issued in the form of 50% restricted stock or restricted stock units and 50% stock options, in each case
to be issued on the first day of the month following initial election or appointment to the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is anticipated that Mr. Graves will be appointed
to be a member of the Audit Committee, Mr. Enyedy will be appointed a member of the Corporate Governance and Nominating Committee, Mr.
Barg will be appointed a member of the Compensation Committee, each of Messrs. Barg, Graves and Enyedy will be appointed as members of
the Strategic Committee, and Mr. Ceesay will be appointed a member of the to-be-combined Science &amp; Technology Committee and Responsible
Animal Use Committee (n/k/a &#8220;New Approach Methodologies and Science Committee&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no arrangements or understandings between
any of the Cooperation Agreement Directors and any other person pursuant to which each was selected as a Director, other than with respect
to the matters referenced under Item 1.01 of this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There have been no transactions since the beginning
of the Company&#8217;s last fiscal year, nor are there any currently proposed transactions, regarding the Cooperation Agreement Directors
that are required to be disclosed by Item 404(a) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Cooperation Agreement, the
Board agreed to limit the size of the Board to no more than 11 members until the expiration of the Cooperation Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 7.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Regulation FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 7, 2025, the Company issued a press release
announcing its entry into the Cooperation Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information furnished in this Item 7.01, including
Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities
of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended,
regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such
filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 11%"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td><span style="font-size: 10pt"><b>Financial Statements and Exhibits. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) <span style="text-decoration: underline">Exhibits</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: left"><a href="dp228602_ex1001.htm"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="dp228602_ex1001.htm"><span style="font-size: 10pt">Cooperation Agreement, by and among the Company and Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., dated as of May 6, 2025</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: left"><a href="dp228602_ex9901.htm"><span style="font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="dp228602_ex9901.htm"><span style="font-size: 10pt">Press Release of Charles River Laboratories International, Inc., dated as of May 7, 2025</span></a></td></tr>
  <tr>
    <td style="text-align: left">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: left"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="3" style="vertical-align: bottom"><span style="font-size: 10pt"><b>CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%"><span style="font-size: 10pt">Date: May 7, 2025</span></td>
    <td style="vertical-align: top; width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 44%">
    <p style="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Matthew L. Daniel</p></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Matthew L. Daniel, Corporate Senior Vice President, General Counsel, Corporate Secretary &amp; Chief Compliance Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwkAMRU/QO4RZi51W6qJLSxWxihQRt6ONMthOSmaseiRv6bRFDIGQ/P/yhZiIFS11jQynRVnAAZu2Vg6hxCsymgt6R7bepOBniTdtHSvjhvUHZuQZ9Mx8Ks/+Pjg7bbFKQSahnIdxAnKWRjPYb0XQ6xmZq67QOK1qUKaCPVPLGp3i9/jhoF5kqHkPSUdkq8mkEE3lKH8gllEMO+rUk/huoSgyEUyGCsSK6dF6V/5yaHoS8hobH2dH+t/BF8mMSlk= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>crl-20250507.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a85s7xRiXgen8uCZHRMWa6HmaP9x5V6uZkxtmt1fYlanyUkfDvVXiyRyVz2EcQB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:CRL="http://crl.com/20250507" elementFormDefault="qualified" targetNamespace="http://crl.com/20250507">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://crl.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="crl-20250507_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="crl-20250507_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>3
<FILENAME>crl-20250507_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>4
<FILENAME>crl-20250507_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://crl.com/role/Cover" xlink:href="crl-20250507.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://crl.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>dp228602_ex1001.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0; font-size: 10pt"><B>Exhibit 10.1</B></P>


<P STYLE="margin: 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COOPERATION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>COOPERATION AGREEMENT</B>
(this &ldquo;<U>Agreement</U>&rdquo;), dated as of May 6, 2025 (the &ldquo;<U>Effective Date</U>&rdquo;), is made by and among Elliott
Investment Management L.P., a Delaware limited partnership, Elliott Associates, L.P., a Delaware limited partnership, and Elliott International,
L.P., a Cayman Islands limited partnership (each, an &ldquo;<U>Elliott Party</U>&rdquo; and, collectively, the &ldquo;<U>Elliott Parties</U>&rdquo;),
and Charles River Laboratories International, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Elliott Parties have engaged in certain discussions concerning the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Elliott Parties desire to enter into this Agreement regarding the appointment of certain new directors to the Board of Directors of the
Company (the &ldquo;<U>Board</U>&rdquo;) and certain other matters, in each case, on the terms and subject to the conditions set forth
herein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, at the time of the
execution of this Agreement, four (4) incumbent members of the Board have voluntarily withdrawn their respective nominations for re-election
to the Board at the Company&rsquo;s 2025 Annual Meeting of the Stockholders to be held on May 20, 2025 (the &ldquo;<U>2025 Annual Meeting</U>&rdquo;),
and their terms on the Board and all committees thereof will end effective as of immediately prior to the Annual Meeting of Stockholders
on May 20, 2025 (the &ldquo;<U>Retirements</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of and reliance upon the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Elliott Parties and the Company agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font-size: 10pt; vertical-align: top">
<TD STYLE="font-size: 10pt; width: 0.5in"></TD><TD STYLE="font-size: 10pt; width: 0.5in">1.</TD><TD STYLE="font-size: 10pt; text-align: justify"><U>Board of Directors</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Composition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
promptly as practicable following the 2025 Annual Meeting, the Board, and all applicable committees thereof, shall take (or shall have
taken) such actions in accordance with the Bylaws (as defined below) as are necessary to fill the vacancies on the Board that will be
created by two of the Retirements and appoint Steven Barg (the &ldquo;<U>Investor Director</U>&rdquo;) and Mark Enyedy (such individuals,
collectively, the &ldquo;<U>Investor Designated Directors</U>&rdquo;) to serve on the Board, each with a term expiring at the Company&rsquo;s
2026 Annual Meeting of Stockholders (the &ldquo;<U>2026 Annual Meeting</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
promptly as practicable following the 2025 Annual Meeting, the Board, and all applicable committees thereof, shall take (or shall have
taken) such actions in accordance with the Bylaws (as defined below) as are necessary to fill the vacancies on the Board that will be
created by two of the Retirements and appoint Paul Graves and Abraham Ceesay to serve on the Board (such individuals, together with the
Investor Designated Directors, collectively, the &ldquo;<U>New Directors</U>&rdquo;), each with a term expiring at the 2026 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>New
Director Agreements, Arrangements and Understandings</U>. Each of the Elliott Parties represents, warrants, and agrees that neither it
nor any of its Affiliates (as defined below) (i) has paid or will pay any compensation to any of the Investor Designated Directors in
connection with such person&rsquo;s service on the Board or any committee thereof, or (ii) has or will have any agreement, arrangement
or understanding, written or oral, with any of the Investor Designated Directors regarding such person&rsquo;s service on the Board or
any committee thereof (for the avoidance of doubt, in the case of the Investor Director, excluding ordinary course employment agreements
or arrangements with any of the Elliott Parties or their Affiliates).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement
New Directors</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(x) any Investor Designated Director is unable or unwilling to serve as a director, resigns as a director, is removed as a director or
ceases to be a director for any other reason prior to the expiration of the Cooperation Period (as defined below) and (y) at such time
the Elliott Parties beneficially own a &ldquo;net long position&rdquo; of, or have aggregate net-long economic exposure to, at least 3.0%
of the then-outstanding Common Stock (as defined below) (the &ldquo;<U>Minimum Ownership Threshold</U>&rdquo;), then the Company shall
appoint, as promptly as practicable, a substitute Qualified Director (as defined below) selected by the Elliott Parties and reasonably
acceptable to the Company (not to be unreasonably withheld, conditioned, or delayed) (such person, a &ldquo;<U>Replacement Investor Designated
Director</U>&rdquo;), to serve as a director of the Company for the remainder of such Investor Designated Director&rsquo;s term. Effective
upon any Replacement of an Investor Designated Director, such Replacement Investor Designated Director will be considered a New Director
and an Investor Designated Director (with any replacement for the Investor Director considered the Investor Director) for all purposes
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(x) any other New Director is unable or unwilling to serve as a director, resigns as a director, is removed as a director or ceases to
be a director for any other reason prior to the expiration of the Cooperation Period and (y) at such time the Elliott Parties satisfy
the Minimum Ownership Threshold, then the Company shall appoint, as promptly as practicable, a substitute Qualified Director selected
by the Company and reasonably acceptable to the Elliott Parties (not to be unreasonably withheld, conditioned, or delayed) (such person,
together with a Replacement Investor Designated Director, each, a &ldquo;<U>Replacement New Director</U>&rdquo;), to serve as a director
of the Company for the remainder of such New Director&rsquo;s term. Effective upon any Replacement of a New Director, such Replacement
New Director will be considered a New Director for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement
New Director Information</U>. As a condition to any Replacement New Director&rsquo;s appointment to the Board, such person shall have
promptly provided to the Company: (i) any consents and information the Company reasonably requests in connection with such appointment,
including completion of the Company&rsquo;s standard forms, D&amp;O questionnaires, other customary onboarding and/or nomination documentation,
and an executed consent to be named as a nominee in the Company&rsquo;s proxy statement and to serve as a director if so elected for the
full term for which such person is elected at any annual meeting of stockholders of the Company, in each case, as provided by the Company,
(ii) information requested by the Company that is required to be disclosed in a proxy statement or other filing under applicable law,
stock exchange rules or listing standards or as may be requested or required by any regulatory or governmental authority having jurisdiction
over the Company and its Affiliates, (iii) information reasonably requested by the Company in connection with assessing eligibility, qualification,
independence, and other criteria applicable to directors or satisfying compliance and legal obligations and (iv) such written consents
reasonably requested by the Company for the conduct of the Company&rsquo;s vetting procedures generally applicable to non-employee directors
of the Company (including such information as is necessary or appropriate for the Company or its agents to perform a background check
in the manner generally performed for non-employee directors of the Company, including an executed consent to such background check) and
the execution of any documents required by the Company of non-employee directors of the Company to assure compliance with Company Policies
(as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company
Policies</U>. The parties acknowledge that each New Director, upon election or appointment to the Board, will be governed by the same
protections and obligations regarding confidentiality, conflicts of interest, related person transactions, fiduciary duties, codes of
conduct, trading and disclosure policies, director resignation policy, and other governance guidelines and policies of the Company as
other directors of the Company (collectively, &ldquo;<U>Company Policies</U>&rdquo;), and shall have the same rights and benefits, including
with respect to insurance, indemnification, compensation and fees, as are applicable to all non-employee directors of the Company. The
Company agrees and acknowledges that (i) no Company Policy currently does, and no Company Policy at any time during the Cooperation Period
will, prohibit any member of the Board (including any Investor Designated Director) from communicating with the Elliott Parties or their
Representatives (as defined below), subject to such director&rsquo;s observance of standard confidentiality obligations and fiduciary
duties to the Company, (ii) no Company Policy currently does, and no Company Policy at any time during the Cooperation Period will, be
violated by the Investor Director receiving indemnification and/or reimbursement of expenses from the Elliott Parties or their respective
Affiliates in connection with his or her service or action as an employee of an Elliott Party or an Affiliate of an Elliott Party (and
not in connection with his or her service or action as a director of the Company), (iii) no Company Policy currently does, and no Company
Policy at any time during the Cooperation Period will, apply to the Elliott Parties and their Affiliates as a result of the Investor Director&rsquo;s
appointment to, or service on, the Board, including Company Policies with respect to trading in the Company&rsquo;s securities, as the
Elliott Parties and their Affiliates are not directors or employees of the Company, and (iv) the Investor Director may provide confidential
information of the Company to the Elliott Parties for the purpose of assisting the Investor Director in his or her role as a director
of the Company and related compliance matters for the Company and the Elliott Parties, subject to, and solely in accordance with the terms
of, a customary confidentiality agreement that certain of Elliott Parties and the Company are entering into simultaneously with this Agreement
(the &ldquo;<U>Confidentiality Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board
Size</U>. The Company agrees that, until the expiration of the Cooperation Period, the size of the Board shall be no greater than 11 members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Committees</U>.
As soon as reasonably practicable following the appointment of the New Directors, the Board shall take all action necessary to appoint
at least one Investor Designated Director to each of the Compensation Committee, Corporate Governance and Nominating Committee and Strategic
Planning and Capital Allocation Committee (the &ldquo;<U>Strategic Committee</U>&rdquo;) of the Board (any such appointment, a &ldquo;<U>Committee
Appointment</U>&rdquo;). If any Investor Designated Director is unable or unwilling to serve as a member of any committee to which such
person has been appointed pursuant to the Committee Appointments, resigns as, is removed as or ceases to be a member for any other reason
prior to the expiration of the Cooperation Period, and at such time the Elliott Parties satisfy the Minimum Ownership Threshold, the Elliott
Parties shall be entitled to select, in consultation with the Company and as approved by the Board (such approval not to be unreasonably
withheld, conditioned, or delayed), a director serving on the Board at the time of such selection (including a Replacement New Director
appointed pursuant to <U>Section 1(c)</U>) to serve on such committee as a replacement for such member (the &ldquo;<U>Replacement Committee
Member</U>&rdquo;). The Board shall take all action necessary to appoint a Replacement Committee Member to such committee as promptly
as practicable, and effective upon such appointment, such Replacement Committee Member will be considered an &ldquo;Investor Designated
Director&rdquo; solely for the purposes of the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
The Company&rsquo;s obligations under this <U>Section 1</U> shall terminate upon any material breach of this Agreement (including <U>Section
3</U>) by any Elliott Party upon five (5) business days&rsquo; (as defined below) written notice by the Company to the Elliott Parties
if such breach has not been cured within such notice period, <I>provided</I> that the Company is not in material breach of this Agreement
at the time such notice is given or prior to the end of the notice period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Strategic
Review</U>. The Investor Director and one other Investor Designated Director will be members of the Strategic Committee. Commencing as
soon as reasonably practicable following the Effective Date, the Board (through the Strategic Committee) shall conduct a comprehensive
strategic review and evaluation of the Company&rsquo;s business and prospects, including an examination of various alternatives to enhance
long-term stockholder value. All decisions coming out of such strategic review will be made only by the full Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cooperation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Disparagement</U>.
Each of the Elliott Parties and the Company agrees that during the Cooperation Period, the Company and each Elliott Party shall refrain
from making, and shall cause its respective Covered Persons (as defined below) not to make or cause to be made, any statement or announcement
that constitutes an ad hominem attack on, or that otherwise disparages, defames, slanders, impugns or is reasonably likely to damage the
reputation of (i) in the case of any such statements or announcements by any of the Elliott Parties or their Covered Persons, the Company
and its Affiliates or any of its or their respective current or former Covered Persons; and (ii) in the case of any such statements or
announcements by the Company or its Covered Persons, the Elliott Parties and their respective Affiliates or any of their respective current
or former Covered Persons, in each case, including: (A) in any statement (oral or written), document, or report filed with, furnished,
or otherwise provided to the SEC (as defined below) or any other governmental or regulatory authority, (B) in any press release or other
publicly available format and (C) to any journalist or member of the media (including in a television, radio, newspaper, or magazine interview
or podcast, Internet or social media communication). The foregoing shall not (w) restrict the ability of any person (as defined below)
to comply with any subpoena or other legal process or respond to a request for information from any governmental or regulatory authority
with jurisdiction over the party from whom information is sought or to enforce such person&rsquo;s rights hereunder, (x) apply to any
private communications among the Elliott Parties and their Affiliates, Covered Persons and Representatives (in their respective capacities
as such), (y) apply to any private communications among the Company and its Affiliates, Covered Persons and Representatives (in their
respective capacities as such), or (z) apply to any private communications between any of the persons listed in (x) on the one hand and
(y) on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting</U>.
During the Cooperation Period, each Elliott Party will cause all of the Common Stock that such Elliott Party or any of its controlling
or controlled (or under common control) Affiliates has the right to vote (or to direct be voted), as of the applicable record date, to
be present in person or by proxy for quorum purposes and to be voted at any meeting of stockholders of the Company or at any adjournment
or postponement thereof or to deliver consents or consent revocations, as applicable, in connection with any action by written consent
of the stockholders of the Company in lieu of a meeting: (i) in favor of each director nominated and recommended by the Board for election
at the 2025 Annual Meeting or, if applicable, any other meeting or action by written consent of stockholders of the Company held during
the Cooperation Period, (ii) against any stockholder nominations for directors that are not approved and recommended by the Board for
election, (iii) against any proposals or resolutions to remove any member of the Board and (iv) in accordance with recommendations by
the Board on all other proposals or business that may be the subject of stockholder action; provided, however, that the Elliott Parties
and their Affiliates shall be permitted to vote in their sole discretion on any proposal with respect to an Extraordinary Transaction
(as defined below); <U>provided</U>, <U>further</U>, that, in the event that both Institutional Shareholder Services and Glass Lewis &amp;
Co. (including any successors thereof) issue a voting recommendation that differs from the voting recommendation of the Board with respect
to any Company-sponsored proposal submitted to stockholders at a stockholder meeting (other than with respect to the election of directors
to the Board, the removal of directors from the Board, the size of the Board or the filling of any vacancy on the Board), the Elliott
Parties and their Affiliates shall be permitted to vote in accordance with any such recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Standstill</U>.
During the Cooperation Period, each Elliott Party will not, and will cause its controlling and controlled (and under common control) Affiliates
and its and their respective Representatives acting on their behalf (such persons, together with the Elliott Parties, collectively, the
&ldquo;<U>Restricted Persons</U>&rdquo;) to not, directly or indirectly, without the prior written consent, invitation or authorization
of the Company or the Board:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)
acquire, or offer or agree to acquire, by purchase or otherwise, or direct any Third Party (as defined below) in the acquisition of, record
or beneficial ownership of, or economic exposure to, any Voting Securities (as defined below), or (y) engage in any swap or hedging transactions
or other derivative agreements of any nature with respect to any Voting Securities, in each case, if such acquisition, offer, agreement
or transaction would result in the Elliott Parties (together with their Affiliates) having beneficial ownership of more than 9.9% of the
Common Stock Outstanding such time, or aggregate economic exposure to more than 19.9% of the Common Stock outstanding at such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)
call or seek to call (publicly or otherwise), alone or in concert with others, a meeting of the Company&rsquo;s stockholders or act by
written consent in lieu of a meeting (or the setting of a record date therefor), (B) seek, alone or in concert with others, election or
appointment to, or representation on, the Board, or nominate or propose the nomination of, or recommend the nomination of, any candidate
to the Board, except as expressly set forth in <U>Section 1</U>, (C) make or be the proponent of any stockholder proposal to the Company
or the Board or any committee thereof, (D) seek, alone or in concert with others (including through any &ldquo;withhold&rdquo; or similar
campaign), the removal of any member of the Board or (E) conduct a referendum of stockholders of the Company; provided that nothing in
this Agreement will prevent the Elliott Parties or their Affiliates from taking actions in furtherance of identifying any Replacement
New Director pursuant to <U>Section 1(c)</U>, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any request for stock list materials or other books and records of the Company or any of its subsidiaries under Section 220 of the DGCL
or any other statutory or regulatory provisions providing for stockholder access to books and records of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;engage
in any &ldquo;solicitation&rdquo; (as such term is used in the proxy rules promulgated under the Exchange Act) of proxies or consents
with respect to the election or removal of directors of the Company or any other matter or proposal relating to the Company or become
a &ldquo;participant&rdquo; (as such term is defined in Instruction 3 to Item 4 of Schedule 14A promulgated under the Exchange Act) in
any such solicitation of proxies or consents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
or submit to the Company or any of its Affiliates any proposal for, or offer of (with or without conditions), either alone or in concert
with others, any tender offer, exchange offer, merger, consolidation, acquisition, business combination, recapitalization, restructuring,
liquidation, dissolution, spin-off, split-off or other similar separation of one or more business units, sale or other disposition of
all or substantially all of the Company&rsquo;s assets, or similar extraordinary transaction involving the Company (including its subsidiaries
and joint ventures or any of their respective securities or assets) (each, an &ldquo;<U>Extraordinary Transaction</U>&rdquo;) either publicly
or in a manner that would reasonably be expected to require public disclosure by the Company or any of the Restricted Persons (it being
understood that the foregoing shall not restrict the Restricted Persons from tendering shares, receiving consideration or other payment
for shares, or otherwise participating in any Extraordinary Transaction on the same basis as other stockholders of the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any public proposal with respect to (A) any change in the number or identity of directors of the Company or the filling of any vacancies
on the Board other than as provided under <U>Section 1</U> of this Agreement, (B) any change in the capitalization, capital allocation
policy or dividend policy of the Company, (C) any other change to the Board or the Company&rsquo;s management, governance or corporate
structure, (D) any waiver, amendment or modification to the Company&rsquo;s Second Amended and Restated Certificate of Incorporation,
as amended from time to time, or Bylaws, (E) causing the Common Stock to be delisted from, or to cease to be authorized to be quoted on,
any securities exchange, or (F) causing the Common Stock to become eligible for termination of registration pursuant to Section 12(g)(4)
of the Exchange Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;knowingly
encourage or advise any Third Party or knowingly assist any Third Party in encouraging or advising any other person with respect to (A)
the giving or withholding of any proxy relating to, or other authority to vote, any Voting Securities, or (B) conducting any type of referendum
relating to the Company, other than such encouragement or advice that is consistent with the Board&rsquo;s recommendation in connection
with such matter, or as otherwise specifically permitted under this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;form,
join, or act in concert with any &ldquo;group,&rdquo; as defined in Section 13(d)(3) of the Exchange Act, with respect to any Voting Securities,
other than solely with Affiliates of the Elliott Parties with respect to Voting Securities now or hereafter owned by them;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into a voting trust, arrangement or agreement with respect to any Voting Securities, or subject any Voting Securities to any voting trust,
arrangement or agreement (excluding customary brokerage accounts, margin accounts, prime brokerage accounts and the like), in each case,
other than (A) this Agreement, (B) solely with Affiliates of the Elliott Parties or (C) granting proxies in solicitations approved by
the Board;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;engage
in any short sale or any purchase, sale, or grant of any option, warrant, convertible security, share appreciation right, or other similar
right (including any put or call option or &ldquo;swap&rdquo; transaction) with respect to any security (other than any index fund, exchange
traded fund, benchmark fund or broad basket of securities) that includes, relates to, or derives any significant part of its value from
a decline in the market price or value of the securities of the Company and would, in the aggregate or individually, result in the Elliott
Parties ceasing to have a &ldquo;net long position&rdquo; in the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sell,
offer or agree to sell, all or substantially all, directly or indirectly, through swap or hedging transactions or otherwise, voting rights
decoupled from the underlying Common Stock held by a Restricted Person to any Third Party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;institute,
solicit or join as a party any litigation, arbitration or other proceeding against or involving the Company or any of its subsidiaries
or any of its or their respective current or former directors or officers (including derivative actions); provided, however, that for
the avoidance of doubt, the foregoing shall not prevent any Restricted Person from (A) bringing litigation against the Company to enforce
any provision of this Agreement instituted in accordance with and subject to <U>Section 10</U>, (B) making counterclaims with respect
to any proceeding initiated by, or on behalf of, the Company or its Affiliates against a Restricted Person, (C) bringing bona fide commercial
disputes that do not relate to the subject matter of this Agreement, (D) exercising statutory appraisal rights or (E) responding to or
complying with validly issued legal process;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enter
into any negotiations, agreements, arrangements, or understandings (whether written or oral) with any Third Party to take any action that
the Restricted Persons are prohibited from taking pursuant to this <U>Section 3(c)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;make
any request or submit any proposal to amend or waive the terms of this Agreement (including this subclause), in each case, publicly or
that would reasonably be expected to result in a public announcement or disclosure of such request or proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restrictions in this <U>Section 3(c)</U> shall
terminate automatically upon the earliest of the following: (A) any material breach of this Agreement by the Company (including a failure
to appoint the New Directors to the Board in accordance with <U>Section 1(a)</U>, a failure to appoint a Replacement New Director to the
Board in accordance with <U>Section 1(c)</U>, or to issue the Press Release (as defined below) in accordance with <U>Section 4</U>) upon
five (5) business days&rsquo; written notice by any of the Elliott Parties to the Company if such breach has not been cured within such
notice period, provided that the Elliott Parties are not in material breach of this Agreement at the time such notice is given or prior
to the end of the notice period; (B) the Company&rsquo;s entry into (x) a definitive agreement with respect to any Extraordinary Transaction
that would result in the acquisition by any person or group of more than 50% of the Voting Securities or assets having an aggregate value
exceeding 50% of the aggregate enterprise value of the Company; (y) one or more definitive agreements providing for the acquisition by
the Company or its subsidiaries of one or more businesses or assets (excluding, for the avoidance of doubt, acquisitions of equipment
or facilities in ordinary course business operations) having an aggregate value exceeding 30% of the market capitalization of the Company
or (z) one or more definitive agreements providing for a transaction or series of related transactions which would in the aggregate result
in the Company issuing to one or more Third Parties at least 15% of the Common Stock (including on an as-converted basis, and including
other Voting Securities with comparable voting power) outstanding immediately prior to such issuance(s) (including in a PIPE, convertible
note, convertible preferred security or similar structure) (provided that securities issued as consideration for (or in connection with)
the acquisition of the assets, securities and/or business(es) of another person by the Company or one or more of its subsidiaries shall
not be counted toward this clause (z)); and (C) the commencement of any tender or exchange offer (by any person or group other than the
Elliott Parties or their Affiliates) which, if consummated, would constitute an Extraordinary Transaction that would result in the acquisition
by any person or group of more than 50% of the Voting Securities, where the Company files with the SEC a Schedule 14D-9 (or amendment
thereto) that does not recommend that its stockholders reject such tender or exchange offer (it being understood that nothing herein will
prevent the Company from issuing a &ldquo;stop, look and listen&rdquo; communication pursuant to Rule 14d-9(f) promulgated by the SEC
under the Exchange Act in response to the commencement of any tender or exchange offer).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything to the contrary in this
Agreement, nothing in this Agreement (including but not limited to the restrictions in this <U>Section 3(c)</U>) will prohibit or restrict
any of the Restricted Persons from (I) making any public or private statement or announcement with respect to any Extraordinary Transaction
that is publicly announced by the Company or a Third Party that is party to such Extraordinary Transaction, (II) making any factual statement
to comply with any subpoena or other legal process or respond to a request for information from any governmental authority with jurisdiction
over such person from whom information is sought (so long as such process or request did not arise as a result of discretionary acts by
any Restricted Person), (III) granting any liens or encumbrances on any claims or interests in favor of a bank or broker-dealer or prime
broker holding such claims or interests in custody or prime brokerage in the ordinary course of business, which lien or encumbrance is
released upon the transfer of such claims or interests in accordance with the terms of the custody or prime brokerage agreement(s), as
applicable, (IV) negotiating, evaluating and/or trading, directly or indirectly, in any index fund, exchange traded fund, benchmark fund
or broad basket of securities which may contain or otherwise reflect the performance of, but not primarily consist of, securities of the
Company or (V) providing its views privately to the Board or the Company&rsquo;s Chief Executive Officer, Chief Financial Officer or General
Counsel regarding any matter, or privately requesting a waiver of any provision of this Agreement, as long as such private communications
or requests would not reasonably be expected to require public disclosure of such communications or requests by the Company or any of
the Restricted Persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Public
Announcements</U>. Not later than 9:00 a.m., Eastern Time, on May 7, 2025, the Company shall issue a press release in the form attached
to this Agreement as <U>Exhibit A</U> (the &ldquo;<U>Press Release</U>&rdquo;). Substantially concurrently with the issuance of the Press
Release, the Company shall file with the SEC a Current Report on Form 8-K (the &ldquo;<U>Form 8-K</U>&rdquo;) disclosing its entry into
this Agreement and including a copy of this Agreement and the Press Release as exhibits thereto. The Form 8-K shall be consistent with
the Press Release and the terms of this Agreement, and shall be in form and substance reasonably acceptable to the Company and the Elliott
Parties. The Company shall provide the Elliott Parties and their Representatives with a copy of the Form 8-K prior to its filing with
the SEC and shall consider any timely comments of the Elliott Parties and their Representatives. Neither of the Company or any of its
Affiliates nor the Elliott Parties or any of their respective Affiliates shall make any public statement regarding the subject matter
of this Agreement, this Agreement or the matters set forth in the Press Release prior to the issuance of the Press Release without the
prior written consent of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Elliott Parties as follows: (a) the Company has the power
and authority to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated
by this Agreement; (b) this Agreement has been duly and validly authorized, executed, and delivered by the Company, constitutes a valid
and binding obligation and agreement of the Company and, assuming the valid execution and delivery hereof by each of the other parties,
is enforceable against the Company in accordance with its terms, except as enforcement of this Agreement may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or similar laws generally affecting the rights of creditors
and subject to general equity principles; and (c) the execution, delivery and performance of this Agreement by the Company does not and
will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable to the Company, or (ii) result in
any breach or violation of or constitute a default (or an event that, with notice or lapse of time or both, could constitute a breach,
violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment,
acceleration or cancellation of, any organizational document or material agreement, contract, commitment, understanding or arrangement
to which the Company is a party or by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Elliott Parties</U>. Each Elliott Party represents and warrants to the Company as follows: (a) such Elliott Party
has the power and authority to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions
contemplated by this Agreement; (b) this Agreement has been duly and validly authorized, executed and delivered by such Elliott Party,
constitutes a valid and binding obligation and agreement of such Elliott Party and, assuming the valid execution and delivery hereof by
each of the other parties, is enforceable against such Elliott Party in accordance with its terms, except as enforcement of this Agreement
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or similar laws generally affecting
the rights of creditors and subject to general equity principles; and (c) the execution, delivery and performance of this Agreement by
such Elliott Party does not and will not (i) violate or conflict with any law, rule, regulation, order, judgment or decree applicable
to such Elliott Party, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of
time or both could constitute a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under,
or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract, commitment,
understanding or arrangement to which such Elliott Party is a party or by which it is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
For purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Affiliate</U>&rdquo; has the meaning set forth in Rule 12b-2 promulgated by the SEC under the Exchange Act; provided, that
none of the Company or its Affiliates or Representatives, on the one hand, and the Elliott Parties and their Affiliates or Representatives,
on the other hand, shall be deemed to be &ldquo;<U>Affiliates</U>&rdquo; with respect to the other for purposes of this Agreement; provided,
further, that &ldquo;<U>Affiliates</U>&rdquo; of a person shall not include any entity solely by reason of the fact that one or more of
such person&rsquo;s employees or principals serves as a member of its board of directors or similar governing body, unless such person
otherwise controls such entity (as the term &ldquo;control&rdquo; is defined in Rule 12b-2 promulgated by the SEC under the Exchange Act);
provided, further, that with respect to the Elliott Parties, &ldquo;Affiliates&rdquo; shall not include any portfolio operating company
(as such term is understood in the private equity industry) of one or more of the Elliott Parties or their Affiliates (unless such portfolio
operating company is acting at the direction of the Elliott Parties or any of their Affiliates to engage in conduct that is prohibited
by this Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
terms &ldquo;<U>beneficial owner</U>&rdquo; and &ldquo;<U>beneficially own</U>&rdquo; have the same meanings as set forth in Rule 13d-3
promulgated by the SEC under the Exchange Act, except that a person will also be deemed to be the beneficial owner of all shares of the
Company&rsquo;s capital stock which such person has the right to acquire (whether such right is exercisable immediately or only after
the passage of time) pursuant to the exercise of any rights in connection with any securities or any agreement, arrangement or understanding
(whether or not in writing), regardless of when such rights may be exercised and whether they are conditional, and all shares of the Company&rsquo;s
capital stock which such person or any of such person&rsquo;s Affiliates has or shares the right to vote or dispose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>business day</U>&rdquo; shall mean any day other than a Saturday, a Sunday or a day on which banks are required or authorized
by law to be closed in Boston, Massachusetts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Bylaws</U>&rdquo; shall mean the Company&rsquo;s Sixth Amended and Restated Bylaws (as amended or restated from time to
time);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Common Stock</U>&rdquo; means the Company&rsquo;s Common Stock, par value $0.01 per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Covered Persons</U>&rdquo; shall mean, (x) in the case of the Elliott Parties, each Elliott Party&rsquo;s controlling and
controlled (and under common control) Affiliates and its and their respective principals, directors, members, general partners, officers,
employees and other Representatives to the extent such Representatives are acting at any Elliott Party&rsquo;s (or any of their respective
Affiliates&rsquo;) direction or on any Elliott Party&rsquo;s (or any of their respective Affiliates&rsquo;) behalf, and (y) in the case
of the Company, the Company&rsquo;s Affiliates and its and their respective principals, directors, members, officers and other Representatives
to the extent such Representatives are acting at the Company&rsquo;s (or its Affiliates&rsquo;) direction or on the Company&rsquo;s (or
its Affiliates&rsquo;) behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Exchange Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
by the SEC thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
terms &ldquo;<U>person</U>&rdquo; or &ldquo;<U>persons</U>&rdquo; mean any individual, corporation (including not-for-profit), general
or limited partnership, limited liability or unlimited liability company, joint venture, estate, trust, association, organization or other
entity of any kind or nature;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Qualified Director</U>&rdquo; means an individual who (i) qualifies as independent of the Company under all applicable
listing standards, applicable rules of the SEC and publicly disclosed standards used by the Board in determining the independence of the
Company&rsquo;s directors and, (ii) other than with respect to the Investor Director, unless the Company otherwise consents, (A) is not
an employee, officer, director, general partner, manager or other agent of an Elliott Party or of any Affiliate of an Elliott Party, (B)
is not a limited partner, member, or other investor in any Elliott Party or any Affiliate of an Elliott Party (unless such investment
has been disclosed to the Company), and (C) does not have any agreement, arrangement, or understanding, written or oral, with any Elliott
Party or any Affiliate of an Elliott Party regarding such person&rsquo;s service as a director of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Representatives</U>&rdquo; means a party&rsquo;s directors, principals, members, general partners, managers, officers,
employees, agents, advisors and other representatives;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Replacement</U>&rdquo; means the appointment of a Replacement New Director pursuant to <U>Section 1(c)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>SEC</U>&rdquo; means the U.S. Securities and Exchange Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Third Party</U>&rdquo; means any person that is not a party to this Agreement or an Affiliate thereof, a director or officer
of the Company, or legal counsel to any party to this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
term &ldquo;<U>Voting Securities</U>&rdquo; means the Common Stock and any other Company securities entitled to vote in the election of
directors, or securities convertible into, or exercisable or exchangeable for, such shares or other securities, whether or not subject
to the passage of time or other contingencies; provided that as it pertains to any obligations of the Elliott Parties or any Restricted
Persons hereunder (including under <U>Section 3(c)</U>), &ldquo;Voting Securities&rdquo; will not include any securities contained in
any index fund, exchange traded fund, benchmark fund or broad basket of securities which may contain or otherwise reflect the performance
of, but not primarily consist of, securities or other interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
All notices, consents, requests, instructions, approvals, and other communications provided for herein and all legal process in regard
to this Agreement will be in writing and will be deemed validly given, made or served, if (a) given by email, when such email is sent
to the email address(es) set forth below, (b) given by a nationally recognized overnight carrier, one business day after being sent or
(c) if given by any other means, when actually received during normal business hours at the address specified in this <U>Section 8</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">if to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Charles River Laboratories International, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">251 Ballardvale Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Wilmington, MA 01887</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Email: matthew.daniel@crl.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">with copies (which shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Davis Polk &amp; Wardwell LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">450 Lexington Ave, New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Louis L. Goldberg, Michael Davis, Shanu Bajaj</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: louis.goldberg@davispolk.com, michael.davis@davispolk.com,
shanu.bajaj@davispolk.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">if to the Elliott Parties:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: #231F20">c/o Elliott Investment Management L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: #231F20">360 S. Rosemary Ave., 18<SUP>th</SUP> floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; color: #231F20">West Palm Beach, FL 33401</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Marc Steinberg, Scott Grinsell</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: msteinberg@elliottmgmt.com, sgrinsell@elliottmgmt.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">with a copy (which shall not constitute notice)
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Olshan Frome Wolosky LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1325 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Steve Wolosky, Kenneth Mantel, Dorothy Sluszka</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email: swolosky@olshanlaw.com, kmantel@olshanlaw.com, dsluszka@olshanlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time, any party may,
by notice given in accordance with this <U>Section 8</U> to the other parties, provide updated information for notices hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>.
All fees, costs and expenses incurred in connection with this Agreement and all matters related to this Agreement will be paid by the
party incurring such fees, costs or expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Specific
Performance; Remedies; Venue; Waiver of Jury Trial</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and the Elliott Parties acknowledge and agree that irreparable injury to the other party would occur in the event any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached and that such injury would not
be adequately compensable by the remedies available at law (including the payment of money damages). It is accordingly agreed that the
Company and the Elliott Parties will be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to seek
to enforce specifically the terms and provisions of this Agreement, in addition to any other remedy to which they are entitled at law
or in equity. FURTHERMORE, THE COMPANY AND EACH ELLIOTT PARTY AGREES: (1) THE NON-BREACHING PARTY WILL BE ENTITLED TO INJUNCTIVE AND OTHER
EQUITABLE RELIEF, WITHOUT PROOF OF ACTUAL DAMAGES; (2) THE BREACHING PARTY WILL NOT PLEAD IN DEFENSE THERETO THAT THERE WOULD BE AN ADEQUATE
REMEDY AT LAW; AND (3) THE BREACHING PARTY AGREES TO WAIVE ANY BONDING REQUIREMENT UNDER ANY APPLICABLE LAW, IN THE CASE ANY OTHER PARTY
SEEKS TO ENFORCE THE TERMS BY WAY OF EQUITABLE RELIEF. THIS AGREEMENT WILL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION
AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and each Elliott Party (i) irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the federal and
state courts of the State of Delaware and the appellate courts thereof for any action, suit, or proceeding (whether in contract, tort
or otherwise) arising out of or relating to this letter agreement. Each party hereby irrevocably and unconditionally waives any objection
to the laying of venue of any action, suit, or proceeding arising out of this letter agreement in such court, and further irrevocably
and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit, or proceeding brought in any
such court has been brought in an inconvenient forum. The parties to this Agreement agree that mailing of process or other papers in connection
with any such action or proceeding in the manner provided in <U>Section 8</U> or in such other manner as may be permitted by applicable
law as sufficient service of process, shall be valid and sufficient service thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of the parties, after consulting or having had the opportunity to consult with counsel, knowingly, voluntarily and intentionally waives
any right that such party may have to a trial by jury in any litigation based upon or arising out of this Agreement or any related instrument
or agreement, or any of the transactions contemplated thereby, or any course of conduct, dealing, statements (whether oral or written),
or actions of any of them. No party hereto shall seek to consolidate, by counterclaim or otherwise, any action in which a jury trial has
been waived with any other action in which a jury trial cannot be or has not been waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If at any time subsequent to the Effective Date, any provision of this Agreement is held by any court of competent jurisdiction to be
illegal, void or unenforceable, such provision will be of no force and effect, but the illegality or unenforceability of such provision
will have no effect upon the legality or enforceability of any other provision of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Agreement shall terminate and be of no further force or effect upon the later of (x) 30 calendar days before the advance notice deadline
set forth in the Bylaws for the nomination of non-proxy access director candidates for election to the Board at the 2026 Annual Meeting
and (y) the first day on which the Investor Director <FONT STYLE="color: #231F20">(or any Replacement New Director for the Investor Director
who is an employee of an Elliott Party)</FONT> ceases to serve as a member of the Board (the period commencing on the Effective Date and
ending on the later of such date in <U>clause (x)</U> or <U>(y)</U>, the &ldquo;<U>Cooperation Period</U>&rdquo;). Upon such termination,
this Agreement shall have no further force and effect. Notwithstanding the foregoing, <U>Sections 7</U> to <U>17</U> shall survive termination
of this Agreement, and no termination of this Agreement shall relieve any party of liability for any breach of this Agreement arising
prior to such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>.
This Agreement may be executed in one or more counterparts and by scanned computer image (such as .pdf), each of which will be deemed
to be an original copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Third-Party Beneficiaries</U>. This Agreement is solely for the benefit of the Company and the Elliott Parties and is not enforceable
by any other persons. No party may assign its rights or delegate its obligations under this Agreement, whether by operation of law or
otherwise, without the prior written consent of the other parties, and any assignment in contravention hereof will be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Waiver</U>. No failure or delay by any party in exercising any right or remedy hereunder will operate as a waiver thereof, nor will any
single or partial waiver thereof preclude any other or further exercise thereof or the exercise of any other right or remedy hereunder.
The failure of a party to insist upon strict adherence to any term of this Agreement on one or more occasions shall not be considered
a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Understanding; Amendment</U>. This Agreement and the Confidentiality Agreement contain the entire understanding of the parties with respect
to the subject matter hereof and supersede any and all prior and contemporaneous agreements, memoranda, arrangements and understandings,
both written and oral, between the parties, or any of them, with respect to the subject matter of this Agreement and the Confidentiality
Agreement. This Agreement may be amended only by an agreement in writing executed by the Company and the Elliott Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation
and Construction</U>. The Company and each Elliott Party acknowledges that it has been represented by counsel of its choice throughout
all negotiations that have preceded the execution of this Agreement, and that it has executed the same with the advice of said counsel.
Each party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred to
herein, and any and all drafts relating thereto exchanged among the parties will be deemed the work product of all of the parties and
may not be construed against any party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision that
would require interpretation of any ambiguities in this Agreement against any party that drafted or prepared it is of no application and
is hereby expressly waived by the Company and each Elliott Party, and any controversy over interpretations of this Agreement will be decided
without regard to events of drafting or preparation. References to specified rules promulgated by the SEC shall be deemed to refer to
such rules in effect as of the date of this Agreement. Whenever the words &ldquo;include,&rdquo; &ldquo;includes,&rdquo; or &ldquo;including&rdquo;
are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;Affiliate,&rdquo;
&ldquo;Representative,&rdquo; &ldquo;Restricted Person&rdquo; and &ldquo;Covered Person&rdquo; shall each include any person who becomes
an Affiliate, Representative, Restricted Person or Covered Person, respectively, subsequent to the date of this agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, this Agreement
has been duly executed and delivered by the duly authorized signatories of the parties as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>ELLIOTT PARTIES</U></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ELLIOTT INVESTMENT MANAGEMENT L.P.</B></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 5%"><FONT STYLE="font-size: 11pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify; width: 2%"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; vertical-align: top; width: 93%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Elliot
Greenberg</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Name:
    Elliot Greenberg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;Vice
    President</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ELLIOTT ASSOCIATES, L.P.</B></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%; text-align: justify"><FONT STYLE="font-size: 11pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; vertical-align: top; width: 93%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Elliot
Greenberg</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Name:
    Elliot Greenberg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;Vice
    President</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ELLIOTT INTERNATIONAL, L.P.</B></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 5%"><FONT STYLE="font-size: 11pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify; width: 2%"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; vertical-align: top; width: 93%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Elliot
Greenberg</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Name:
    Elliot Greenberg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-size: 11pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Title:&nbsp;&nbsp;&nbsp;Vice
    President</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>COMPANY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</B></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; vertical-align: top; text-align: justify; width: 25%"><FONT STYLE="font-size: 10pt">/s/
    James C. Foster</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 69%">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">James C. Foster</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Chairman, President &amp; CEO</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<HR SIZE="3" ALIGN="CENTER" STYLE="width: 100%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exhibit A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Form of Press Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Filed separately as Exhibit 99.1 to the Current Report on Form 8-K.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>dp228602_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in; color: Red"><B><IMG SRC="image_001.jpg" ALT="">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 12pt"><B>NEWS RELEASE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Charles River Laboratories Announces Governance
Updates and </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Strategic Review to Enhance Long-Term Stockholder
Value</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><B>&ndash; Board Approves Appointment
of Four New Directors &ndash;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><B>&ndash; Strategic Planning and Capital
Allocation Committee of the Board </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><B>to Conduct Comprehensive Strategic
Review of the Company&rsquo;s Business &ndash;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><B>&ndash; Enters into Cooperation Agreement
with Elliott Investment Management &ndash;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WILMINGTON, MA, May 7, 2025</B> &ndash; Charles River Laboratories
International, Inc. (NYSE: CRL) today announced that four new directors will join its Board of Directors and that four long-time members
of the Board will not seek re-election at the 2025 Annual Meeting of Shareholders. The Company also announced changes to its Board committees
and a strategic review of the Company&rsquo;s business focused on enhancing long-term value for shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Charles River&rsquo;s Board of Directors has agreed to appoint four
new directors, Steven Barg, Abe Ceesay, Mark Enyedy, and Paul Graves, who will join the Board effective following the 2025 Annual Meeting
of Shareholders to be held on May 20, 2025. Four existing directors, Robert Bertolini, Deborah Kochevar, George Massaro and Richard Wallman,
have announced their intentions to not seek re-election at the end of their previously elected terms at the 2025 Annual Meeting. Following
the new director appointments, the Company's Board will consist of eleven directors, nine of whom will be independent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As part of these actions, Martin Mackay, Ph.D. will serve as Lead Independent
Director, Nancy Andrews, M.D., Ph.D. will serve as Chair of the Corporate Governance and Nominating Committee, and Reshema Kemps-Polanco
will serve as Chair of the Compensation Committee. Virginia Wilson will remain Chair of the Audit Committee. Additionally, Steven Barg,
Mark Enyedy and Paul Graves will join the Strategic Planning and Capital Allocation Committee, with Paul Graves serving as Chair. The
Board will also establish a New Approach Methodologies and Science Committee (NAMS) through the combination of the Science and Technology
and Responsible Animal Use committees, which will be chaired by Craig Thompson, M.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board, through the Strategic Planning and Capital Allocation Committee,
will conduct a comprehensive strategic review and evaluation of Charles River&rsquo;s business and prospects, including an examination
of various alternatives to enhance long-term stockholder value. The committee will present its recommendations to the full Board upon
completion of its review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Charles River also announced a Cooperation Agreement with Elliott Investment
Management L.P., Charles River&rsquo;s largest investor, under which Elliott has agreed to customary standstill, voting, confidentiality,
and other provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">James C. Foster, Chair, President and Chief Executive Officer of Charles
River Laboratories said, &ldquo;Charles River has a long track record of taking actions to navigate dynamic market conditions and position
the Company for growth. The initiatives announced today are a continuation of this effort for the benefit of all our stakeholders. We
are pleased to welcome Steven Barg, Abe Ceesay, Mark Enyedy, and Paul Graves to the Board, whose seasoned industry expertise, strong operational
and leadership experience, and fresh perspectives will add significant value as we continue to execute our initiatives to optimize our
operating performance and drive efficiencies across Charles River&rsquo;s portfolio, and enhance long-term shareholder value.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Foster continued, &ldquo;We would also like to extend our gratitude
to Robert Bertolini, Deborah Kochevar, George Massaro and Richard Wallman for their long-standing service to the Charles River Board.
Their leadership, strategic counsel, and many contributions over the years have been instrumental in the growth of Charles River to become
a leading global partner for the discovery and development of life-changing novel drugs and therapeutics.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We also welcome the opportunity to collaborate with Elliott
Investment Management as we undertake these initiatives. They have deep experience in the healthcare space and have shown confidence in
and commitment to enhancing the long-term potential of Charles River. Our Board and management look forward to working together to continue
to position Charles River as the scientific partner of choice, poised to capture the significant opportunities ahead of us, and to deliver
exceptional value for all our stakeholders,&rdquo; Mr. Foster concluded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Elliott Partner Marc Steinberg said, &ldquo;Charles River plays a mission-critical
role in biomedical research and development, and we have long admired the Company&rsquo;s market-leading capabilities and strong competitive
positioning under Jim Foster&rsquo;s leadership. We believe that the Company&rsquo;s current value is significantly disconnected from
its underlying potential, and as Charles River&rsquo;s largest investor, we see a substantial opportunity to unlock that value. The changes
announced today &ndash; including the new additions to the Board and the undertaking of a comprehensive strategic review &ndash; are the
right ones, and we look forward to continuing our constructive partnership with Jim Foster and the Charles River Board and leadership
team.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Cooperation Agreement with Elliott will be filed in a Current Report
on Form 8-K with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gordon Dyal &amp; Co. Advisory Group LP is serving as financial advisor
and Davis Polk &amp; Wardwell LLP is serving as legal counsel to Charles River.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>New Board Member Biographies</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Steven Barg</B> is Global Head of Engagement at Elliott Investment
Management L.P. and brings significant M&amp;A and capital markets expertise, as well as public board experience in the CDMO/CRO space.
Prior to joining Elliott in February of 2020, Mr. Barg spent 30 years in investment banking, most recently as a Participating Managing
Director at Goldman Sachs. Mr. Barg established and led what became the firm's Global Activism and Shareholder Advisory practice; founded
and led the M&amp;A Capital Markets practice; and ran Asian Equity Capital Markets in Hong Kong. In addition, Mr. Barg served on both
the Asian and Global Equity Commitments Committees and was Global Head of Diversity for the Investment Banking Division. Prior to joining
Goldman Sachs, Mr. Barg served as a Managing Director in Equity Capital Markets at UBS and Credit Suisse, with postings in New York, Hong
Kong, and London.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Barg previously served on the boards of Cardinal Health and Catalent.
He holds an M.B.A. from the Stanford University Graduate School of Business and a B.A. from Wesleyan University. In addition, Mr. Barg
was a Henry Luce Scholar in Hong Kong and a Coro Fellow in Public Affairs in New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Abe Ceesay</B> is Chief Executive Officer of Rapport Therapeutics
and has nearly two decades of executive and public company biopharmaceutical industry experience. Prior to joining Rapport, he served
as President of Cerevel Therapeutics from May 2021 through February 2023, and was previously Chief Executive Officer of Tiburio Therapeutics.
Prior to joining Tiburio, Mr. Ceesay held positions including Chief Operating Officer at scPharmaceuticals, Head of Commercial at Keryx
Biopharmaceuticals, Vice President of Marketing at Ironwood Pharmaceuticals, and roles of increasing responsibility at Sanofi, formerly
Genzyme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Ceesay serves on the boards of Rapport Therapeutics, Pacira BioSciences,
and Life Science Cares, as well as on the Board of Trustees at The Museum of Science in Boston. He holds an M.B.A. from Suffolk University&rsquo;s
Sawyer School of Management and a B.A. from Ithaca College.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Mark Enyedy</B> has nearly three decades of combined general management,
business development and legal experience in the biotechnology industry. He brings significant M&amp;A and capital markets experience,
as well as public healthcare board experience. He most recently served as the President and Chief Executive Officer of ImmunoGen from
2016 until it was acquired by AbbVie in 2024. Mr. Enyedy joined ImmunoGen from Shire plc, where he served as Executive Vice President
and Head of Corporate Development, leading the company's strategy, M&amp;A, and corporate planning functions and providing commercial
oversight for the company's pre-Phase 3 portfolio. Previously, Mr. Enyedy served as Chief Executive Officer and a director of Proteostasis
Therapeutics, following 15 years at Genzyme Corporation in diverse roles, most recently as President of the transplant, oncology, and
multiple sclerosis divisions. Before joining Genzyme, Mr. Enyedy was an Associate with the Boston law firm Palmer &amp; Dodge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Enyedy serves on the board of BioMarin and previously served on
the boards of ImmunoGen, Ergomed plc, LogicBio Therapeutics, Akebia Therapeutics, Fate Therapeutics, and Keryx Biopharmaceuticals, as
well as The American Cancer Society of Eastern New England and The Biotechnology Innovation Organization. Mr. Enyedy holds a J.D. from
Harvard Law School and a B.S. from Northeastern University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Paul Graves</B> is Chief Executive Officer of Rio Tinto Lithium
(previously Arcadium Lithium until it was acquired by Rio Tinto in March 2025) and brings significant executive leadership and public
company board experience, as well as investment banking and M&amp;A expertise. Previously, Mr. Graves served as Chief Executive Officer
of Livent and was an integral part of the merger with Allkem that created Arcadium Lithium. Previously, Mr. Graves was the Executive Vice
President and Chief Financial Officer of FMC Corporation. Before joining FMC, he was a partner at Goldman Sachs, serving in a variety
of roles, including as Head of Natural Resources for Asia and Global Head of Chemical Investment Banking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Graves served on the board of Arcadium Lithium until its acquisition
by Rio Tinto, and also previously served on the boards of Livent and Lydall. He holds a B.A. from Nottingham Trent University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U></U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Caution Concerning Forward-Looking Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release includes forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;may,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project,&rdquo; and other similar expressions that predict or indicate future events
or trends or that are not statements of historical matters. These statements also include statements regarding: the Company&rsquo;s plans
or prospects, expectations and long-term goals associated with our business; the company's expectations concerning future financial and
operating performance, including the company's commitment to, and ability to create long-term value for shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking statements are based on Charles River&rsquo;s current
expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results
to differ materially from those stated or implied by the forward-looking statements. Those risks and uncertainties include, but are not
limited to, the impact of the events described herein, including results and impact of the Strategic Planning and Capital Allocation Committee&rsquo;s
comprehensive strategic review and evaluation of Charles River&rsquo;s business and prospects; and finalizing the appointment of the anticipated
new directors. Furthermore, these and other risks relating to the Company are set forth in the documents filed by Charles River with the
Securities and Exchange Commission, including without limitation, the Risk Factors in both the Company&rsquo;s Annual Report on Form 10-K
filed February 19, 2025. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially
from results and events currently expected by Charles River, and Charles River assumes no obligation and expressly disclaims any duty
to update information contained in this press release except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B></B></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>About Charles River</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Charles River provides essential
products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around
the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly
what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who
need them. To learn more about our unique portfolio and breadth of services, visit <FONT STYLE="color: blue"><U>www.criver.com</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%">Investor Contact:</TD>
    <TD STYLE="font-size: 10pt; width: 50%">Media Contact:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">Todd Spencer</TD>
    <TD STYLE="font-size: 10pt">Amy Cianciaruso</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">Corporate Vice President,</TD>
    <TD STYLE="font-size: 10pt">Corporate Vice President,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">Investor Relations</TD>
    <TD STYLE="font-size: 10pt">Chief Communications Officer</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">781.222.6455</TD>
    <TD STYLE="font-size: 10pt">781.222.6168</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: blue"><U>todd.spencer@crl.com</U></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: blue"><U>amy.cianciaruso@crl.com</U></FONT></TD></TR>
  </TABLE>

<P STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  .@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V/Q!KE[HB
M-<)I7VFS1 7G^T!-I+8QMP2>W/O6Y7/^-_\ D4+[_MG_ .C%KH* "BBB@ HH
MHH **** "BBB@ HHHH **J:C>-86;W(MY9UCY=(AEMO<@=_I6)%\0?"TL/F?
MVQ"F.JN"K#\,5I&G.2O%7(E4C%VD['345YGKOQ@T^WS!HEN]].> [@J@/TZF
MJ^DK\3->D6[DOHM+MVY59(5Z?[N"?S-=/U*HH\U1J*\_\C!XJ#ERP][T/5**
MYU]5U#P_8+-KNRYA7B2ZM(S\GNR>GN*:?'WA80>=_;5MMQG'.?RQFN=49OX5
M?T-O:Q7Q.WJ=)17E>M_%]&D^R>'+%[J=CM6653@GV4<FI]'M_B=?R+=W-_;6
M<9Y$,\2GC_= R/SKH>"J1CS5&H^NYC]:@Y<L$WZ'IM%5K+[6+5!?&$W 'S&'
M.T_3/-6,^]<1TW%HHHH&%%%% !1110 4444 <_XW_P"10OO^V?\ Z,6N@KG_
M !O_ ,BA??\ ;/\ ]&+704 %%%% !17/>-O%"^#?"USK;6ANA 5'E!]F=S =
M<'UK<M9OM-I#/MV^:BOCTR,T 2T444 %%%% !1110 5S>K>!/#FLW!N+O38_
M.8Y:2,E"WUQUIG@OQBOC"#4Y5LC:_8;U[0@R;]^W^+H,?2NGJX3E!WB[$RA&
M2M)7.:M?!^E:' TNB:9:K>J,H\V6R?3)Y&?45B77Q3M=*E:VUC1M0L[I."FT
M,I]PW&17H%07%I;7:A;FWBF4=!(@;'YUK&K%N]9<WSU,I4VE^[=OD>1ZA\4-
M;\0.;#PWI+H9/EWE?,<CZ=!^-&B?!VXNO])UZ]\EG.XP6X!/XGH/PKUVWM;>
MU7;;P10KZ1H%'Z5-72\<X1Y</'E7WLQ^J<[YJKYOR.,M/",7@^"2ZT"U6[E'
M+0SXWN.X1\<'VZ5G3?%[2+7='=:;J,%RO#0N@!!],YKT2JESIEC>,&NK*WG8
M=#)$&(_,5A&M"3O73E\[,U=*45:D[?(\CN_B%XI\5S_8?#6G26Z-P70;GQZE
MCPM:VD_##5)&6[UGQ'>BY/)6WE.1_P ")KTR&WAM8_+@ACB0?PQJ%'Y"L7PM
MXAN?$5O>RW.DSZ<;:Z>!5F))D"_QC@<&M98RRY:,5%?>_O9G'"W?-5ES/\#3
MTZSDL+1;>2[FNMO228@MCW(ZU<HHKA;N[LZTK*P4444AA1110 4444 <_P"-
M_P#D4+[_ +9_^C%K?) !). .YK \;_\ (H7W_;/_ -&+3_&LT\'@?79;8D3)
M83%".H.PT <5/X\\4>+=7N]/\ Z?:FSM',<VJWN?++]P@'7]:AO=>^)_@R Z
MEKEKIFMZ7'S<&R!26)>Y P.GT-;_ ,'[>V@^%NB_9@H\R-GD([N6.<UVL\<4
ML$D<RJT3J5=6Z$$<YH \P^*FLV?B#X(W6JZ?)YEK<B%T)ZCYQD'W!XI]EXL\
M8>)+& >#-(M(].BC6,:CJ;%5F8#!V(.<9[U7^)UKHME\%=1M] %JM@DJ;5M6
M#(&\P9Z'UKT?0+>*U\/:;!"@2-+6,*H' &T4 >=_\)UXP\):_IUCXVTZP;3]
M0E$$5_8$X1STW __ %JZ_P ;^,;;P7H8OI('NKF:00VMLA^:60]!]*Y;X[*I
M\$6;X^9=3@VGTZUI?$+Q!HVC#1DN]%.LZQ)-NTVT5<L)!CY@>V..: ,Z&?XP
M:C&+H0>'M-5AN6VFWNX'H2,\U>\*>-M:F\5R^$_%FFP6FK"'SX);5B8IT'7&
M>A_P-5(]4^+.J -!H>B:5&W_ #]3-(Z_@IKF-)T[7M/^/VE?\)%JT6H7TVGR
MOF%-B1KA@%4>G% '5>//B5=^#O&&F:5'8+=P7=JT@1%)E>7)"*O.,$@=JE\/
M/\4+C6[:[UM-(M]*E.9;./F2)<<8/<].]9OBF*.;]H#P@)$#!;&5AD="-^#7
MJM 'EOP4XT_Q.?\ J-3?TIUWX]\2^*=:N]+\ Z?;26UH_ESZK>$^4']$ Z_K
M]*Q_A[+-#X"\?RV^?.2]O&0CJ"$-4/A<_C^#P%9?\([9:!)8.\CA[B1Q(S;B
M#NP>O'Y8H Z"[U7XK^%+=M1U.VTK7;"/YITLU*2HO<C@9_(UUL7C[1I_ 4GB
M^%V>PCB+LF/G##C8??.!6&US\6F4AM.\,$'@@R2?XUF^#?AQJ,/@WQ)H'B)[
M:.WU2<R1BTDW+%GGC/3! X]J 'V6H_%7Q78Q:IIW]BZ+93C?!%<*TDC(>A/!
M_I3[;QOXL\*^(=/TGQS963VFH2>3;ZE9$A?,/0,#_P#6JK8:3\6?"5G'I^G7
M&CZU80+MA^T920(.@SD?UI;CXC:MI=U9P^/O!8M+2295CO8V$T:/V.#T_/-
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M*VD60B''+-W"YS^76LO[)\967[7_ &EX?1OO?8O*./\ =W8_K7-SOXED^/\
MX@?0H].DOH;.-8QJ!;"Q;4SLQWR?U-=CYOQ;_P"?;PQ^<O\ C0!:\$^/I]<U
M.Z\/Z]I_]F>(;,;I(,Y25/[R'TKGM4^)WB&/QUK/A32=(@O;Z-D2Q&" ,C+O
M(<XP,CTI;;PKXWO_ (EZ-XEUG^QH/L:M%*MF[!I(R#U!SGK4O@R)&^./CF0H
M"Z1P!6QR 1S_ "'Y4 ='X.@\?0WLY\6W>F7%L\>8A:+AHWST/ R,?6BNRHH
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M&TB;*6T?IZ9_^O4WA?P_JEA\5/%NKW-JT=C?)"+>7<"'VCGC.:[^B@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  07,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001100682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1397316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">251 Ballardvale Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">222-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /<YIUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /<YIUH2=B+S\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( /<YIUJ36(7L6P0  (L0   8
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ ]SFG6I>*NQS
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M4$L! A0#%     @ ]SFG6D;'34B5    S0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #W.:=:$G8B\_(    K @
M$0              @ '#    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #W.:=:F5R<(Q &  "<)P  $P              @ 'D 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( /<YIUJ36(7L6P0  (L0   8
M      " @24(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #W.:=:GZ ;\+$"  #B#   #0              @ &V#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( /<YIUJ7BKL<P    !,"   +              "
M 9(/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /<YIUJJQ"(6,P$  "("   /
M              "  7L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #W
M.:=:)!Z;HJT   #X 0  &@              @ ';$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #W.:=:99!YDAD!  #/ P  $P
M            @ ' $@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"   *%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp228602_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://crl.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>crl-20250507.xsd</File>
    <File>crl-20250507_lab.xml</File>
    <File>crl-20250507_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="dp228602_8k.htm">dp228602_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp228602_8k.htm": {
   "nsprefix": "CRL",
   "nsuri": "http://crl.com/20250507",
   "dts": {
    "schema": {
     "local": [
      "crl-20250507.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "crl-20250507_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crl-20250507_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "dp228602_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://crl.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp228602_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-07",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp228602_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://crl.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950103-25-005798-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-005798-xbrl.zip
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M(69N+_:PLKG%X Q1 -*!:^O6Z!H"ZQO/R&TO' 5=0^VW69SD#U6UI3JG0.@
M!^8M/:+MC<KC%A*0>Q65RGV@1%B$N,2J?=>&/LL<2TU_6 L#=!QA /O?%4[@
MY-3"%061_UCQ0.M72^W8FR.E_K?'KJ.J95P"6AG=0W=F=ML/F)=*':#H/[/@
MF=IDNC6S[EJ)\%>9GI+$:@=.2Z+@G9'$GIM[5WRQ#ZX7:0L=&W3/"W PZ$Z.
MC8@4A>7L%-;?B[_((94Y*8F-X_0EM[6$%JV9ZASK[OYT_L1,_\593>"QF$J^
M/*41UBG%SWFGL7KICSN( I\=@G[\SPU[1A=4@^]J@8Z=J:GE;U!+ P04
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MKJ 4>;D0Y4HO_?\9LR>Q?<ZB_9W@$2'J*:NT&JWZKK\-C';+S)N:U*1I4&A
MG+W%+T#@H0I4J^-#;<;R>3%//32NLKGQZ&GQB.4!O-UFJ9I!I3'X*GAGD./;
M"P,:8-QDZ(@("+T!-J$;#GDDRD,_H"(8U:(]G9^EARR )/Z\OR</1*CW#I9D
MEWV6.WKJ.,,8$.OZ[&UP<\R3N=[ ("!\JUOH5"]%]0K02CTC5E:!?E>5H+P6
MV^^7US==RT]RL]XD_UKAE,@M_P502P,$%     @ ]SFG6O;D!9M1!P  R5<
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M(-XJ2\R<H60$5%,EZ1N*J=.G.DW+)"FGD<^AQ+2(5A[#R+A@H'921-B1J/7
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M? RP'/3ZYC@W-A;H^UR@$XPO@2\",%^R2: 8!LYT:O/Q!1ZNB.YGZ.6P4V8
MQF!!U\B0&A97\-&L^LHUZJ$_(DQ;0N]-U'FN5E?UE0SP9=!<(\ANZ5@Z\:$]
MD H[]TT'>=\>(/T7JNMAV!)@1$VUB<%O1M[;^)X(Q]$V/!$LSVVLU4F$*%I2
M/<QR$J;8TA&*3$J ZR#Y!&2U5HMMPK3>N4@3TS](Y_^%W.G&LRY1)*3L\  D
M5LICZ+.WG,+4^;Z-.(!/9)2TYXS1 Q;"?8;]3"SJNI7.LBI_15=/YDI8F32
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M^^:=HDBEYUH3_!="=GOO_P%02P,$%     @ ]SFG6L?0=2GA0P  "6<! !,
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M!3WA7PJ:NGE)#C\N8&<JF"KL%'R"O$ -XU)'"NX8C@5?34MZJIP/WL-;S62
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MU,FL8KHJY^-Q,DQT-ES@<5]/$F!T< ]Q?%3JAA^R_#K5(Q"'_'2=LPMQ.A&
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M[PV?F^@B-"QC$Q$H$=M,9* X6",$-9(T*0$N6@)0!*]E Q1VT21UM]9AH/\
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M;0\0XX6EE\AG*TI=)59S?Y7;WJ=N>\69%V96U':6IH)P.>MN;APD^U'1D-E
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MV7XU>?D8_ZO&:7Y'S8+J\_D=(6O/XG2J7G&M\^MC]?3IC[M[=\W.W\;%$%1
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M?DA44@IBN1(;%:_ 0>Z*S)O-EY=$T[WTK5*RMKQHIH5%XDMG$$6DH<MPDG.
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M$Q;K?9HB.R7Y)D2UJR_2@=4(['M+"YT0%SZ$A">:"QI!28.;":YOF$\Y:.O
MHJ(:4'>D&E/ C0[?&7GXX7B;F\&LX-3COZY]PJK/H_W_>7FT?P&?$+XP:2[J
M-?=-?OGX:/__W?';UU(AGSY,%?+I=Q6R?C..3C S]:1W<:%^QR3@T]=1C5GZ
M0*W8''MY$VRZ]/.@9[8JZ4(PHDE=Q0CEPWTD; 7LH<8D.(GXH'=\?''6/3@Z
M>?./1T\>T=]GW<-#\_?:<[Q.1M4$?[K[@[U20V 3V/WXN3+_>D0T\K)_OOX+
M"-1M&*=FY4"=CPS%]0_5P2FNY^0?CYZN/7D[S!U5G[Y\M8\>&B^S_JAW@3;)
MR\?P#9W+7;[>/_\[7J99X]');[V+/J6EO^V>=-]PACI7O?.27S[N'^+_G'\J
M0?AGO_:C9DM@#BT4M#[Y!R/>TZI:;\@29B&7]:<?X-3\:#Z^:[L$!H<IG,CA
M7R%(%87;:YOUV9-CJ;=Z?D]NG)_9]B\RQ=6*P)+]E:D^>_K#7;.1Q^5C,;DV
M-]Z $"-,@?N^2TOX<NL%NTN:^:J$<MN+MF)2I#^1(L?SX(-5WKFZF7X_VC_?
MT?:Q#.]YTUOY6X+(I#B],[ S*3+0?M2/24_[?)6Q821^U__N0?\SBE'WXN+T
MX*C;[UU$W]6A^U"'K.;S2:SF[M4AJ_G</RO\K@Y]EYG?U:'O1_M='?KVU*$_
MG^9#0 ,GA#+0/?ZN_'SW!7WW!7U7?KY+R._*SU__:#]/^;D[U>?;'>S/J93=
MK8_JSG2TE;3+L4N!"7,Q2Z'2NT7M73VSVE6_SZG )AW\VCU'8*OSH]]ZY^JX
M^^KTO-L_/3^"CVJ:[]')P4[;)GY)[OY9A-9DZO<E<^2^_KQ*]=L5U?3^M;^5
MVNM*]9K6 "H=S_B_8IS;P8YZG9<5ED1]D269O7SVP[=SPK?2B;XQ87X7I_/G
M.1%69;ZQ(SF8Q$E!XUL]2EK5'/1.6^>Z=+^7*UO>&U=H+C?D)_YX%UF)MTG)
MNY^$/]J/7X%^C_YOCV11]_CH#4BE@QZ*1"N:/+7LT=U*\5?[O8^39)!4JJM<
M\M6?IN_ UWD+[=/KG(LPSZBMW[E.$6SCBV[9'<S[?UXGB'U;<DT 5K3'I3(G
M_NS9SIYMP(? YL ESC4"AV%1+*WWE^U_[7RY?.:[.!@SU"HF\],+=3JC2HOG
MZC@NJ_OB.7>6!NSMP^-7IX=_$-_^M?_V>/__ U!+ P04    " #W.:=:TLM"
M"0P7  "B7   $P   &1P,C(X-C R7V5X.3DP,2YH=&WE7&MS&S>R_<XJ_@=<
MW=ILMHJ2)27.;FS%=:F';<64K)+DN/+I%C@#DHAF!@PP(YKY]?=T Y@'22F*
MR]XKKS>ULC2<P0#].'VZT>#!Z^NST8M^[^#UR? 8_PKZW\'UZ?7HY,7!$_\O
M/GT2/CXX?'O\J[BZ_G5T\M/6Q!3E,[&W.R_%M<Z5$^=J(2Y-+HN!OS 05\KJ
MR18>Q*,7[>>VG?Y#^8>?BUS:J2Z>B=VM%]\48S=_?O#DXL^>*=6'<EMF>HKG
MK)[.NL,<'+XX^3#38UV*'W_<V3MX<OCB 6-V!XA3^<2/;ICX0P79>@UNW>6?
MW^DB"$,7J:)Q=G>>TK7$9,8^$Y<JY2D=G)Z]$E>71S]MZ5Q.U?_N[N[M_#:?
M;HGAZ/JGK2CX+^OGW;KYK-*\ST8_XL50S\NWY]>;3&M_7K+RSD_>7XG+D]')
M\.K$+YJ>^'1K_PQK^L0#=AT^@6J49=$<S:3-,,REOE56C.386%D:JW%I6!2F
M*A+\]LK@PT+B]W[OW3R5):[)(A6?U( V3_'?)8>K$NM64YW 1F\UQBJ-."EF
MM&8Q,L5T^UK97%R5)KF9F2Q5MM_[16:5^O)$X'_N[#^M?75=&M\4J72SY^+0
M2)N*X7QN80&.?C&Z*'/<V.^9B7AI*LMO/=96)3 ;)\*3GQY:[IOQ_Z.$&KNY
MR&11Z&+*GG$DY[J46;\WS#*3R%*;0AR9/-=EJ92 Z,J9"M+]CQ<5/.G(%&F5
ME"2"N54S53C 32.[?B\X71 ,W2:+Y3?6_5Z9YTX<5DX7RGU]UG5"5YR SY$,
MS5Q9;TK#J57*N^%"ES-QDF7:E*4X+>"F[)_B3!;@*?SK?X+46"SO3T=GI^>O
MKM^>#\39$/^72_'/@=C?W7]*BXL+%7<'M7[OE*97L!AE-H#$DAWQ[?FO5R?/
MQ-'EZ!_ _12CRA#[4MBC+,$P 70%)IK60+?0629^ QP*7;K@RC#?!@D)!IJ'
M,XHA)=8G<I6/H50&T 8%>+C"E,(I=2.LVE89QB%=8P2ZC19)(;F2F3A3JB2D
MP0A76*KR$<GMB.O&>83,G&FM(T$LFT(FL*1FPDF$)$R'YBN%J_',WNN2X^B2
M$Y-4#N-CIHKC)4W,KY8BYBT%2=QDA6O/]/$RI:TN)6HP:%W#,PDMDR>F)%7I
M@R.KN]_K& O>5*I;58A#O&D@AF/($S*72S)A>P,W7ZH4?Y *+F25B5=6WM($
M%S/3,K3&6M1D0M9Q2Y)%@%F0S.\P$K:SMI707#&!F<I8:>1#^[O>B79\1%<?
MM&/[:BW@TL!H2W&('R;3A1Z(8T5N-1-O3#)3M](.Q"ME[%1A1.>D-;R:2PV[
MPX3?RRPCR?=[,ZRLXUY*6P(XP :LG6=WGQNH(@TFB<?F9*.F<ME2\'TT'HS.
MW>,SM,0@L7Z/[FDK*NJ04!-K;MG]WUW;3Q-,%"*BB>"]I-B6I, !.,)#=[F_
M'=*F=&BN."=ZU+8_=&(N;1E$[* IEKYC0X7\\$]R0W9[,=LYWO'+<\J22IT8
M*9D"4.N5]GO15P;B',BPA"Y2JQ8T&I[>/ B\#YJM4<?.";M5*P5ANSHWN280
MAY'6M,K[SZ5R,Y5+\4;E<[=]8<#*$D-A\IZ7Y)BP6R%I.^(73:+14KS7@-+"
MS]-B;(BA,\"P2G79?G*8X@('F&S9]?U^K^7PJ_Z^XNKW4TNQB5D",8@.M,>D
M-?.C8=4<)/J]EC5SH !MD.-,NQEB !D+<WZ9S. WY<RD2-^G.F1]5XE6I(>&
MSWY[/CR[0NB<65--9SQY1):Q]F$VBBD^1V-<JV16T*!+'WB@M3DYU3B#. N=
M8WWOG&K%)\)"8$GM4 FM!?X^7HHC*_44JX(:H29O6X_9QZXCC \Z$OL8=0>[
M3@*]EB2P%L%>"^8TH**07"MF<["KHSL] $-P<[@Q%J2+)(.Q\]00)F0>5,Q!
M!C& P!CV%!C6K:<;*J31#2EP31KM"8)G+K6VO9:Q$$?TE>@*8 0? E9D'25(
M9I,*]WE3KN8T#5I_IN+B_).T\D=M$/50_[6]+5YJ!.9G<.&I0G:I?J_(9S"L
MV-X.]>6#X]-?XCO]2-MCD'^3/Q,_4"T581F"K:\=9H!LL8=7.41NJF9^Q(S7
M&7Y<Q79IYKR2^D)\\2Y7WUIKBJMY+JZ7<ZQI:.58)\\1&W+E5WQN:)E[[8>>
MQ*?HDT;T!T\@A0T"&5LE;[;'"HP38\Y9BNV)_L"3NNC*+\SUCM';DZ%)>DU\
M>JJYRMCEYI1/W)'Q46BI4[[1S@7BZV;GSC '/ -GID<I.%<%>:('V#APE]R"
MXT.GTB[AN\ $T,,,R=.MH0@\(/R9:(KX&B92+@<>TPT\E#B:N=6.G/91^^#/
MDNX^(GKH8-T#'RQ!40!"O#0/QC.M)N+D@THJ9M]O)Q.=*-L"TGYO0R7520VP
M_R9+20%=G;.8&1H%P#JY8:3SB48I;QAIDX88RUL])3:4+@M@;T*+N%$EX[_V
M=S%@&Z<]*K<8+.=@4VL6Y<RC+:@-].51NL7'??IK%0<3:+2H6D%<.TH]C"UY
M-!I]K HUT4P8P78$I0^PD)LF)7T/LD'# 9:E\\:T4!EP6GU<4A2A/T10L&SP
M!(>Q38'1P;-AJ3!3]0&>4VH'2H2_2;RU*U%9C@;%A&B*,SWW=S,[\>^;0.LS
M@6L<^'3-S62:"@<0U%"[A$WX[!8J7*@H+<4ACRU$L3C:<L9'9E[J7/_!GR%L
M^DEA>O@%,LUKAIM:,C!%!D838_*5(!*[.[P:/+E$,JB-7\&&H-OD@"'H?F/9
M(!^S6Y[9Z)&U?!M/>@^B8"JDL0R<F;X)LB\Y2:S(W"';LDIA@OC@TZ2PT?)U
MJ.DP'I("F6@G*MIGU\W96G?ZO6O_8&UY@Q9'2^""3F5>?SFY+"W9ZG'E79LR
M(!YZJ217'V[)_>! NL @%>$^>&)('KRGKS$\G_R3]\$'>!XT]6EFQGB4,K\"
M]T3?3K5+Z*4^44GAK)F9<WC!L)F>J&TN*M$(!>[+8+/5-!:^8-=SA9DG[DNP
ML\:BV)8B0I$4S)Q<JX(7+SD2FBSSV*XZD9@JBYN*KQX<.,(2+H:TN@4*C,9+
MK\Y4J388167.%#CU+"$8=7,9 ((?<#.S*.KXRT]X</-<FF=04_!8)6HP86Y*
M'[77#&5'O*V"V49[C"O*C+DA&UG09P3GQG*@*LU4<<AG*7EG9<>+\6C%%"$9
MFHTC?"L)46L#Q&22F=&$QG.C0]1(Y+RLK-=)&X,;_3!&SJ@(@0$JYQT)3Z8J
MHQ?V>^I#HN8^!+0*DYOBUB#8K.@"$&4_*GW41";RMXL@2\32A"*M+H!^T_NH
MR#R32R(CN7;$U[83"Y$F%"VMR=@6QQI.D=(U0;D91IZM0H,7.BR>S9-YC4QS
M3M4WE9$]@=F.0 0=(R7(@BHQ4(C=E-8AJR-_Z?>B.=$#GKG^K/.@I(;DUA!+
M% 28EVE,TA?D-TTDJ:Q5=40'SVF96+;T4%@4OL8XL2;O]RBYY-=G2X[?T96\
M!.1=<7J=?2^(OQ#?<M68HHGWQR[J5 6R_QL__7;&[(OZY/)= A=W0IJ$/=8Z
M91JI8IM(1="N@2IL+_QI12&^2'K/A*U03XX &7.U*:P"1@ '?D7%?D7QR]>S
M P0P*V-X;71;SW%#:!5=0@?843+_$@*/W['YTS0OEKTF.F.62\EAL-A+198"
M*EE 3L#T?VV_\<]R40D\U#;N=/+!6XPO(;&;/VHP>X54".LZ7L(COI'Y_#DF
M3N559)0&M.25-=5<C"[87YLZYT13H9B\2/H[?4@\1O;DQ(7);L)8[V$XB/29
M&*T-D:FIS"(C(YOM!L?'+#-J5FOO]-Y35-K_BHI*^U]-48D,X-T+NMM#XQEO
M.(M#;9 /S6? @H,G[UY\TFZ SV/&K?H ;^_#15_Y3.5U('DGQ;3FV>5#:F*,
M@F,++^]$>''&B##DCY-0<??<Q+5+"4SFJ0Z ?+L:9PB#8[\?NT;9CX[/WCXY
MNGSK"3LROPNK#5-CVM\AE(FSQ0,OU=A65%S#DO9W:3>6:">M&X_3U+_;#4D?
MM1LT:<98%C=<@,L1(*ERI)BL<$F)^)].]-Q7%U@,O.=Y7.]UEN(5R"ZEM%<R
MF2$/J5]:;P:I&%@1QXEZ('64(2V::)O_O5;(D**W=KG?(&I5&FJLGELJ9)&?
M3@R1C#0687Q,CPJ(VQUG0?C-8W2WQ62'3N/GR>\54:/5VR&?UT08WQC:ZCTM
M:KK3%BGM O+>-T!EYHMD?E!Z15A0'+].HURS[>)CZ4*NF>,Q!0='S\44NI43
M'GIET4U<#]T1JR;1[W44LCYE5FQ49=V(0(N^0QQ0V;O#*U^Z! 77I;BJ$/;C
M/B&8=,FN@!'(+W]%)C=@ ?9[)$'/X$:F2!\Y3Z@%U>H(:-3,=4KR4\=I+G[1
MA=<:LNJPR0:IT=Y\O_<:J0NT0#H69SN'.\,=YOMABTX6$ZK.OBMJ3;^R,JVH
M&'"%E-5P(GW8WCV3HAGCO7*96F+@YOD[C+3?6["R7ZL"OC.J$C\^DH>.B8<W
M'!EK "+4UT ?7WAH&DXF4MN.<A^U$H'X31$X OX]%?=+R3D2)4)UK<F#"A75
M"^ EK*!<4/Z?(#%@Y:MZ("Z4>T$EH4*.]'8.Z,H!V!5GOBOE9 ;X=;>-$QD(
MJDRPU6$:KK5U0%:G+"7)G<EZH_ -./M[]69P'0UP];M!C34MT[Y'*-=Z#,)O
M.N_9%'W"?=[BO,A]2U#,KETK=_3O>UO7JN/[ "\NN>B(#-J-:$AXJ:SGX:5X
MH^SR0[]WN"IC// +E4T[TO+XQ5P<X=R:8F%,*M;>Q"'!9%ZUF"YHFJ.';.PF
MH%+"DL:XDH69Z 'A<DX9.Z!6%7\L<_6H/:*E&[8KMXYFFYQ@@."?:"N)\H6F
M"Q?VY$9ZTC1B  DY2V](C6DWF9$U69@_!SQ^@SBKG*IR[CM,:KISB"A"X>PN
MY+RJ)A-*NAK0B\60?N]*+I8PI 8[VY73%?0\+6<R(;#+D)T];L4!REI[6(QE
M;4R:(<=OHY)OED&PFJH":LQ:U5;HK6[&:%?@/7>B)'6=>P+'RKJ_IL8P5M#'
M4%^_+\:0MD)^6W7I51[,;^O2TH;$T"0?O+%ZFN=58>"NH>ZVO[OW@ZB*4@.>
M2T9&F8#]A&:@X7C\BV9) #V_]YPV=%L1].&F[G@@JYIW)Q/:2P1(-R!.,VUF
MU 4I[TT-TL4VM>-V)316-4,_5.@C#"4TVN;TDO<XEM1CS&/[SZ0JDM:N+FVD
M^RII#:S]GF&7HI);I)S-FQ QMH&93HGOFNU!BE\QD S:XFD6?9<RO$/6S9)8
M^(6%I4')@%W'FULM#&HZ4_>>ANR%4@X/N[7(J.:EJ7^2UJ$\FF_(9SK1@58)
M(1:.) 4YFR)A4V=!]GMYE95ZGM'.0J8LPIFCX4,/@CCD++Z.@V$^'4FP35&B
MX0R$'/=Y/# 2U(E,+CC_ <YFT$0H)QV;]+'#T@-J0M\]%WRPZ>NJ#GWWU52'
M5CV^RRDX?=$&P4L7 776$RJ?,C<<I$;4@3BQ4]HB\G@Z,E.='*Z0T8$8WJBQ
MEBL77Y*?=2_1ZYDUBDVD40)P8C@B:C*$(U)  ZLI"*RNX+NJY)+*B:3M Y\%
MG133C'&,FE#)HSNQ\K0HS*T'I;=V*@O]!__1"2.!XXB?J7?9AZ37TMZ2\$;
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M<_&6SU:Z9V(D7?D5)0-/_VHR\#"Z_I$Z>D+?,>Z_=)R^F_S_ %!+ 0(4 Q0
M   ( /<YIUHYY42!(0,  - +   0              "  0    !C<FPM,C R
M-3 U,#<N>'-D4$L! A0#%     @ ]SFG6DAK.9S]"@  ?X8  !0
M     ( !3P,  &-R;"TR,#(U,#4P-U]L86(N>&UL4$L! A0#%     @ ]SFG
M6O;D!9M1!P  R5<  !0              ( !?@X  &-R;"TR,#(U,#4P-U]P
M<F4N>&UL4$L! A0#%     @ ]SFG6G%=/(N#'   PY$   \
M ( ! 18  &1P,C(X-C R7SAK+FAT;5!+ 0(4 Q0    ( /<YIUK'T'4IX4,
M  EG 0 3              "  ;$R  !D<#(R.#8P,E]E>#$P,#$N:'1M4$L!
M A0#%     @ ]SFG6M++0@D,%P  HEP  !,              ( !PW8  &1P
G,C(X-C R7V5X.3DP,2YH=&U02P4&      8 !@"! 0   (X

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>dp228602_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crl-20250507.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001100682</identifier>
        </entity>
        <period>
            <startDate>2025-05-07</startDate>
            <endDate>2025-05-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-07" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-07" id="Fact000004">0001100682</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-07" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-07" id="Fact000010">2025-05-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-07" id="Fact000011">CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-07" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-07" id="Fact000013">001-15943</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-07" id="Fact000014">06-1397316</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-07" id="Fact000015">251 Ballardvale Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-07" id="Fact000016">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-07" id="Fact000017">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-07" id="Fact000018">01887</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-07" id="Fact000019">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-07" id="Fact000020">222-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="AsOf2025-05-07" id="Fact000021">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-07" id="Fact000022">CRL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-07" id="Fact000023">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="AsOf2025-05-07" id="Fact000024">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-07" id="Fact000025">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-07" id="Fact000026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-07" id="Fact000027">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-07" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
